Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, IN, United States.
Pfizer Inc, Worldwide Research and Development, Cambridge, MA, United States.
Int J Pharm. 2018 Jul 30;546(1-2):226-234. doi: 10.1016/j.ijpharm.2018.05.035. Epub 2018 May 14.
Excipients are crucial components of most pharmaceutical formulations. In the case of a solid oral dosage formulation containing the salt form of a weakly ionizable drug, excipient selection is critical, as some excipients are known to cause salt disproportionation (conversion of salt to the free form). Therefore, robust formulation design necessitates an in-depth understanding of the factors impacting salt disproportionation during processing or storage as this can negatively impact product quality and performance. To date, there is an incomplete understanding of key excipient properties influencing salt disproportionation. Specifically, the potential roles of amorphous excipient glass transition temperature and excipient hygroscopicity, if any, on salt disproportionation are still not well understood. Furthermore, the relationship between the compression and the extent of salt disproportionation is an unknown factor. Herein, by utilizing various grades of polyvinylpyrrolidone (PVP), its copolymer, copovidone (PVPVA), and magnesium stearate, a systematic investigation of disproportionation was performed using pioglitazone HCl as a model salt of a weak base. It was observed that there was a poor correlation between excipient hygroscopicity and the rate and extent of disproportionation. However, powder compression into compacts enhanced the rate and extent of disproportionation. This work focused on disproportionation of the salt of a weak base, as basic drugs are more prevalent, however, salts of weak acids may have similar tendencies under relevant conditions. The knowledge gained from this study will help in understanding the role of various excipients with respect to salt disproportionation, paving the way for designing stable salt formulations.
辅料是大多数药物制剂的重要组成部分。对于含有弱离解药物盐形式的固体制剂,辅料的选择至关重要,因为一些辅料已知会导致盐的歧化(将盐转化为游离形式)。因此,稳健的配方设计需要深入了解在加工或储存过程中影响盐歧化的因素,因为这会对产品质量和性能产生负面影响。迄今为止,对于影响盐歧化的关键辅料性质还没有完整的理解。具体来说,辅料无定形玻璃化转变温度和辅料吸湿性的潜在作用(如果有的话)对盐歧化的影响仍未得到很好的理解。此外,压缩和盐歧化程度之间的关系是一个未知因素。在此,通过利用不同等级的聚乙烯吡咯烷酮(PVP)、其共聚物共聚维酮(PVPVA)和硬脂酸镁,以盐酸吡格列酮为弱碱模型盐,对歧化进行了系统的研究。结果表明,辅料吸湿性与歧化的速率和程度之间没有很好的相关性。然而,将粉末压制成片剂会加速和增加歧化的速率和程度。这项工作主要关注弱碱盐的歧化,因为碱性药物更为常见,然而,在相关条件下,弱酸的盐可能也有类似的趋势。从这项研究中获得的知识将有助于了解各种辅料在盐歧化方面的作用,为设计稳定的盐配方铺平道路。